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Abstract
Dorsal root ganglion stimulation (DRG-S) is a form of neuromodulation that can target specific dermatomes
to obtain better coverage of the distal extremity. Previously proposed mechanisms of action for DRG-S
focused on the dorsal root ganglion (DRG) itself, without consideration of orthodromic effects in the dorsal
horn and antidromic effects on the nerve root and sympathetic chain. Diabetic peripheral neuropathy (DPN)
is an axonal neuropathy that affects around half of all patients with diabetes mellitus, causing severe pain
and sensory impairment in the distal extremities. We present a case of a patient with DPN in both feet, in
addition to low back pain, who underwent a DRG-S trial with right T12 and S1 leads. The trial was performed
unilaterally for seven days, allowing the patient to compare the treated versus the untreated (left) side. Pain,
disability, general health status, and quality of life measures improved significantly. In addition to the
significant pain relief in the low back and feet, the patient had near resolution of other DPN-related
symptoms, including numbness, bluish discoloration, and allodynia of both feet. He also demonstrated
functional and psychological benefits with only a single-sided lead. Overall, the placement of unilateral T12
and S1 DRG-S leads resulted in symmetric improvement of DPN symptoms. A possible mechanism of action
is antidromic propagation of action potential signaling into the sympathetic chain to a central ganglion and
then to the contralateral sympathetic chain. Given the DRG's ability to directly affect afferent sympathetic
fibers with low-frequency stimulation, DRG-S may be an effective neuromodulatory treatment for DPN.
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Dorsal root ganglion stimulation (DRG-S) is an effective form of neuromodulation therapy for several
refractory chronic pain syndromes [1-4]. Compared to dorsal column spinal cord stimulation, DRG-S may
provide better relief for neuropathic pain syndromes of the distal extremities due to the ability to specifically
target nociceptive transmission in DRGs associated with the dermatomes of the feet [5]. Moreover, DRG-S
likely modulates neural transmission beyond the previously proposed local mechanisms at the dorsal root
ganglion (DRG) itself [6] through orthodromic effects at the dorsal horn and antidromic effects in the nerve
root and sympathetic chain.
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Diabetic peripheral neuropathy (DPN) is a length-dependent axonal polyneuropathy that begins in the distal
lower extremities. An estimated 50% of patients develop DPN within 25 years after the initial diagnosis of
diabetes mellitus. Of these, up to 40-50% will develop severe refractory pain [7]. Traditional spinal cord
stimulation (SCS) has been used to treat DPN with some benefit, with a systematic review demonstrating
>50% pain relief in 63% of patients [8].
This case study reports on the near-resolution of bilateral DPN symptoms from unilateral DRG-S trial at the
T12 and S1 levels and reviews possible mechanisms responsible for this phenomenon. The patient described
in this report provided written informed consent for the publication of this report.

Case Presentation
A 61-year-old diabetic male patient presented with chronic low back pain and DPN. Significant
comorbidities included depression and anxiety. He rated his pain 8/10 cm on visual analog scale (VAS) for
the low back and 9/10 cm in the feet. He described his pain in the feet as constant, burning, and throbbing,
with intermittent shooting pain between the toes in both feet. Additionally, he complained of numbness and
tingling, blue discoloration, and a “cold feeling” in his feet in a symmetrical stocking distribution. His low
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back pain was non-radiating and characterized as aching and throbbing. He had foot pain at rest and could
not walk more than 50 feet without stopping. Physical examination revealed dusky and blue feet that were
cold to touch, with reduced sensation to pinprick and vibration, allodynia, and paresthesias present
symmetrically in both feet. His lumbar spine showed a decreased range of motion with pain, positive facet
loading maneuvers, and tenderness to palpation of the lumbar paraspinal muscles. An MRI of the lumbar
spine demonstrated facet arthropathy with foraminal stenosis.
The patient failed multiple conservative treatments for his bilateral foot pain, including gabapentinoid and
non-steroidal anti-inflammatory medications. He experienced back pain relief from lumbar medial branch
blocks and radiofrequency ablations. However, the corticosteroids would consistently elevate his blood
glucose concentrations for several days after these procedures. Considering we were unable to effectively
treat his foot pain, combined with the blood glucose elevation from the corticosteroids used for his back pain
treatment, we explored other treatment options to address both problems effectively. We offered the patient
a trial of DRG-S, given our positive experience with DRG-S for both neuropathic pain and axial low back
pain, after he received psychological evaluation clearance for his baseline depression and anxiety. As per
usual practice at our institute, regardless of bilateral symptoms, we performed a unilateral stimulation trial
for seven days. A unilateral trial has several advantages over a bilateral one, including the ability for the
patient to compare the treated side with the untreated side and a decreased risk of complications and postprocedural pain. Leads were trialed at the right T12 and S1 to cover the low back and distal extremity pain
(Figure 1). During the single-sided trial, DRG-S settings included a frequency of 20 Hz, a pulse width of 260
us, and an amplitude of 0.425 mA.

FIGURE 1: Fluoroscopic Imaging of DRG Lead Placement
Unilateral lead location at the right T12 and S1 DRG in a patient who experienced almost complete resolution
of bilateral foot pain. Arrows indicate placement of the electrodes in proximity to the DRG within the
intervertebral foramen.
(A and B) AP and lateral views of S1 DRG lead placement, respectively. (C and D) AP and lateral views of T12
DRG lead placement, respectively.
DRG, dorsal root ganglia; AP, anteroposterior
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We collected VAS, EuroQol-5D (EQ-5D), 36-Item Short Form Survey (SF-36), and Oswestry Disability Index
(ODI) data at baseline and at the end of the seven-day trial as part of standard of care (Table 1).

Measurement

Baseline

End of DRG-S trial

Back

8

1

Feet

9

0

Back pain related disability, ODI

72

16

Global health status, EQ-5D

0.15

0.88

Physical component score

16

50

Mental component score

24

63

Pain, VAS (in cm)

Quality of life, SF-36

TABLE 1: VAS, EQ-5, SF-36, and ODI data
Pain (VAS), back pain related disability (ODI), global health status (EQ-5D), and physical and mental functioning (SF-36) at baseline and completion
of the dorsal root ganglion stimulation trial
DRG-S, dorsal root ganglia stimulation; VAS, visual analog scale; ODI, Oswestry Disability Index; EQ-5, EuroQol-5D; SF-36, 36-Item Short Form
Survey

During the trial, DRG-S lead placement at the right T12 and S1 resulted in a substantial decrease in pain in
both feet and in a decrease in low back pain. Improvements in back pain, related disability, and quality of
life accompanied the improvements in pain. We observed an improvement in skin color in both feet, and the
allodynia and numbness in both feet were resolved. Furthermore, the patient could walk without limitations
and participate in other physical activities that he was previously restricted from doing.

Discussion
We observed a profound bilateral treatment effect with unilateral T12 and S1 DRG-S in a patient with DPN.
An extensive literature search found only one other published case report describing bilateral pain relief
with unilateral DRG lead stimulation involving a patient with bilateral inguinal neuropathy [9].
Diabetic neuropathy is characterized by autonomic dysfunction and microangiopathic disease [10]. Chemical
and thermal neurolysis of the lumbar sympathetic chain have yielded positive results in patients with
DPN [11]. As the sympathetic nervous system mediates vascular tone, modulation of the sympathetic
nervous system with DRG-S may induce vasodilation. Those include filtering high-frequency afferent signals
at the dorsal root ganglia [12], antidromic propagation of low-frequency action potentials, inhibitory signals
into the sympathetic chain, and dorsal root reflex, which is a direct activation of afferent sympathetic fibers
that have the ability to act as efferent fibers and release transmitters [13].
We surmise the mechanism of action underlying the observed bilateral changes in the patient’s feet to be
sympathetic modulation at the DRG with crossover fibers in the sympathetic chain and/or the sacral
plexuses. These mechanisms can occur through orthodromic and antidromic effects of electrical stimulation
at the DRG, such as those listed above (Figure 2) [14]. Sympathetic crossover has been described in several
case reports involving sympathetic nerve blockade with local anesthetics and several rodent studies [15-17],
but no cases involving neuromodulation have been reported. Anatomical dissections have also
demonstrated sympathetic communication from the contralateral chain [18]; however, microscopic
interactions between neuronal interfaces in the central ganglions, namely celiac, hypogastric, and ganglion
impar, also require consideration.

2020 Chapman et al. Cureus 12(9): e10735. DOI 10.7759/cureus.10735

3 of 5

FIGURE 2: S1 Dorsal Root Ganglion Stimulation
S1 dorsal root ganglion stimulation lead in place demonstrating antegrade propagation of action potentials
and crossover to the contralateral side through the sympathetic nervous system (figure adapted with
permission) [14].

In addition to the sympathetic nervous system collaterals, a central mechanism cannot be excluded as
having played a role in the observed treatment effects. Interconnections between the limbic system,
hypothalamus, and brain stem structures comprise the central autonomic network, which processes visceral
and somatic afferent signals and, in part, controls sympathetic outflow through fibers descending in the
dorsal longitudinal fasciculus. Tracer studies indicate that these descending fibers ultimately project
bilaterally, albeit with an ipsilateral dominance, onto preganglionic sympathetic neurons located in the
intermediolateral nucleus of the spinal cord [19]. Therefore, stimulation of autonomic afferent fibers at a
unilateral DRG site may partially modulate bilateral sympathetic outflow through supraspinal circuits with
bilateral descending projections, though most effects would occur ipsilaterally.
Beyond the DPN improvements, the patient’s back pain improved significantly during the DRG-S trial, albeit
unilaterally. We previously published a case series demonstrating T12 lead placement efficacy in treating
chronic axial back pain [2]. The fact that the therapeutic improvement with DPN symptoms was observed
bilaterally, while the somatic back pain only improved ipsilateral to lead placement, highlights the different
means by which DRG-S exerts its effects. Back pain relief occurs through unilateral DRG and superficial
dorsal horn modulation, whereas DPN improvement likely occurs through bilateral modulation of the
sympathetic nervous system, as described above.
This case report underscores the role of the sympathetic nervous system in DPN. Given the DRG's ability to
modulate afferent sympathetic fibers with very low-frequency stimulation, DRG-S has the potential to be a
powerful neuromodulatory tool for DPN. In our experience, an S1 lead is usually sufficient to cover
neuropathic pain of the entire foot, including the L4 and L5 dermatomes, as was seen in this case [20].

Conclusions
We successfully treated bilateral DPN symptoms with a unilateral DRG-S trial. Improvements in functioning
accompanied a considerable reduction in bilateral foot pain. Furthermore, ameliorations in skin color,
allodynia, and numbness were observed on both feet. More extensive prospective studies exploring the
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antidromic effects of DRG-S across the sympathetic chain could further elucidate the hypothesized potential
mechanisms of action behind DRG-S treating DPN. Furthermore, larger prospective studies exploring the
efficacy of DRG-S as a tool to treat diabetic polyneuropathy may support a potential new role for DRG-S.
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